Menu

Ruth Wright

Female inventors and gender imbalance in patent applications

Where are the female inventors? Despite the recent fashion for children’s books designed to redress the representation of historical female inventors, according to the Intellectual Property Office, women make up just 7 per cent of UK patent holders. Ruth Wright and others discuss the possible reasons so few women are named...

Read more

Asking the right questions to optimise life sciences IP

This article was originally published on Biotech and Money. Supporting commercial goals by asking ‘why?’ As there is no one-size-fits-all approach to developing an effective IP strategy, GJE ensures it has a thorough understanding of its clients’ objectives and developments within their businesses so that it is able to offer the...

Read more

Biotech vs Medtech: Differences in Mapping an IP Portfolio

This article was originally published on Biotech and Money as a two-part series. Read part one here. IP portfolio management is often overlooked, but is extremely important if the goal is to protect products or services in the most cost-efficient way possible. However, the process of mapping an IP portfolio to...

Read more

Biotech vs Medtech: Divergence in Intellectual Property Strategy

The landscape of innovation and investment in the healthcare sector has changed dramatically with the digital revolution and the rise of medtech – the physical devices used in healthcare – ranging from drug delivery devices to diagnostic kits and software for the interpretation of health and wellbeing data. Investors in...

Read more

What makes a digital health business a medtech business?

These days, with digital transformation and disruption on everyone’s lips, there is no shortage of companies across a wide range of sectors trying to claim to be a technology business as a badge of honour. It has never been more challenging to determine whether a company is genuinely a technology...

Read more